Mechanisms of miR‑128‑3p in inhibiting osteoblast differentiation from bone marrow‑derived mesenchymal stromal cells

Zhang,Wen; Zhu,Yu; Chen,Junsheng; Wang,Jiaxing; Yao,Chen; Chen,Chen

doi:10.3892/mmr.2020.11600

Mechanisms of miR‑128‑3p in inhibiting osteoblast differentiation from bone marrow‑derived mesenchymal stromal cells

Authors:
- Wen Zhang
- Yu Zhu
- Junsheng Chen
- Jiaxing Wang
- Chen Yao
- Chen Chen
View Affiliations

Affiliations: Department of Orthopedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, P.R. China, Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, P.R. China
Published online on: October 14, 2020 https://doi.org/10.3892/mmr.2020.11600
Pages: 5041-5052
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The authors' previous study demonstrated that miR‑128 may exert an inhibitory effect on the osteogenic differentiation of bone marrow‑derived mesenchymal stem cells (BM‑MSCs), but its downstream mechanisms remain to be elucidated. The aim of the present study was to investigate the microRNA (miRNA/miR) and mRNA profiles of differentiated and undifferentiated BM‑MSCs and explore new downstream targets for miR‑128. The sequencing datasets of GSE107279 (miRNA) and GSE112318 (mRNA) were downloaded from the Gene Expression Omnibus database. The differentially expressed miRNAs (DEMs) and genes (DEGs) were identified using the DESeq2 method. The target genes of DEMs were predicted by the miRwalk 2.0 database. The hub target genes of miR‑128 were screened by constructing the protein‑protein interaction (PPI) network and module analysis. The expression levels of miR‑128 and crucial target genes were validated by reverse transcription‑quantitative (RT‑q) PCR before or after transfection of miR‑128 mimics to BM‑MSCs. The miRNA expression profile analysis identified miR‑128 as one of the significantly downregulated DEMs (total 338) in differentiated BM‑MSCs compared with the undifferentiated control. A total of 103 predicted target genes of miR‑128‑3p were overlapped with upregulated DEGs. By calculating the topological properties of each protein in the PPI network, 6 upregulated genes (KIT, NTRK2, YWHAB, GAB1, AXIN1 and RUNX1; fold change was the highest for NTRK2) were considered to be hub genes. Of these, 4 were enriched in module 4 (RUNX1, KIT, GAB1 and AXIN1; RUNX1 was particularly crucial as it can interact with the others), while one was enriched in module 7 (YWHAB). The expression levels of miR‑128 and these 6 target genes during the osteogenic differentiation were experimentally confirmed by RT‑qPCR. In addition, the expression levels of these 6 genes were significantly reversed after transfection of miR‑128‑3p mimics into rat BM‑MSCs compared with the miR‑control group. These findings indicated that miR‑128‑3p may inhibit the osteoblast differentiation of BM‑MSCs by downregulation of these 6 genes, particularly RUNX1, YWHAB and NTRK2.

View Figures

View References

1	Confalonieri D, Schwab A, Walles H and Ehlicke F: Advanced therapy medicinal products: A guide for bone marrow-derived MSC application in bone and cartilage tissue engineering. Tissue Eng Part B Rev. 24:155–169. 2018. View Article : Google Scholar : PubMed/NCBI
2	Gopal K, Amirhamed HA and Kamarul T: Advances of human bone marrow-derived mesenchymal stem cells in the treatment of cartilage defects: A systematic review. Exp Biol Med (Maywood). 239:663–669. 2014. View Article : Google Scholar : PubMed/NCBI
3	Guntur AR and Rosen CJ: The skeleton: A multi-functional complex organ. New insights into osteoblasts and their role in bone formation: The central role of PI3Kinase. J Endocrinol. 211:123–130. 2011. View Article : Google Scholar : PubMed/NCBI
4	Shin YS, Yoon JR, Kim HS and Lee SH: Intra-articular injection of bone marrow-derived mesenchymal stem cells leading to better clinical outcomes without difference in MRI outcomes from baseline in patients with knee osteoarthritis. Knee Surg Relat Res. 30:206–214. 2018. View Article : Google Scholar : PubMed/NCBI
5	Zhang Y, Liu Y, Wu M, Wang H, Wu L, Xu B, Zhou W, Fan X, Shao J and Yang T: MicroRNA-664a-5p promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by directly downregulating HMGA2. Biochem Biophys Res Commun. 521:9–14. 2020. View Article : Google Scholar : PubMed/NCBI
6	Ge JB, Lin JT, Hong HY, Sun YJ, Li Y and Zhang CM: MiR-374b promotes osteogenic differentiation of MSCs by degrading PTEN and promoting fracture healing. Eur Rev Med Pharmacol Sci. 22:3303–3310. 2018.PubMed/NCBI
7	Huang J, Meng Y, Liu Y, Chen Y, Yang H, Chen D, Shi J and Guo Y: MicroRNA-320a regulates the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting HOXA10. Cell Physiol Biochem. 38:40–48. 2016. View Article : Google Scholar : PubMed/NCBI
8	Tu XM, Gu YL and Ren GQ: miR-125a-3p targetedly regulates GIT1 expression to inhibit osteoblastic proliferation and differentiation. Exp Ther Med 2016. 12:4099–4106. 2016. View Article : Google Scholar
9	Wang H, Xie Z, Hou T, Li Z, Huang K, Gong J, Zhou W, Tang K, Xu J and Dong S: MiR-125b regulates the osteogenic differentiation of human mesenchymal stem cells by targeting BMPR1b. Cell Physiol Biochem. 41:530–542. 2017. View Article : Google Scholar : PubMed/NCBI
10	Zhang S, Liu Y, Zheng Z, Zeng X, Liu D, Wang C and Ting K: MicroRNA-223 suppresses osteoblast differentiation by inhibiting DHRS3. Cell Physiol Biochem. 47:667–679. 2018. View Article : Google Scholar : PubMed/NCBI
11	Zhang W, Yao C, Wei Z and Dong Q: miR-128 promoted adipogenic differentiation and inhibited osteogenic differentiation of human mesenchymal stem cells by suppression of VEGF pathway. J Recept Signal Transduct Res. 37:217–223. 2017. View Article : Google Scholar : PubMed/NCBI
12	Chang CC, Venø MT, Chen L, Ditzel N, Le D, Dillschneider P, Kassem M and Kjems J: Global microrna profiling in human bone marrow skeletal-stromal or mesenchymal-stem cells identified candidates for bone regeneration. Mol Ther. 26:593–605. 2017. View Article : Google Scholar : PubMed/NCBI
13	Sun Y, Cai M, Zhong J, Yang L, Xiao J, Jin F, Xue H, Liu X, Liu H, Zhang Y, et al: The long noncoding RNA lnc-ob1 facilitates bone formation by upregulating Osterix in osteoblasts. Nat Metab. 1:485–496. 2019. View Article : Google Scholar : PubMed/NCBI
14	Love MI, Huber W and Anders S: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
15	R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing; Vienna, Austria: 2012, simplehttp://www.R-project.org/
16	Dweep H and Gretz N: miRWalk2.0: A comprehensive atlas of microRNA-target interactions. Nat Methods. 12:697. 2015. View Article : Google Scholar : PubMed/NCBI
17	Kohl M, Wiese S and Warscheid B: Cytoscape: Software for visualization and analysis of biological networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
18	Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al: STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43((Database Issue)): D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
19	Tang Y, Li M, Wang J, Pan Y and Wu FX: CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 127:67–72. 2015. View Article : Google Scholar : PubMed/NCBI
20	Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, et al: Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44:W90–W97. 2016. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Zou W, Greenblatt MB, Brady N, Lotinun S, Zhai B, de Rivera H, Singh A, Sun J, Gygi SP, Baron R, et al: The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2. J Exp Med. 210:1793–1806. 2013. View Article : Google Scholar : PubMed/NCBI
23	Matta C, Szűcs-Somogyi C, Kon E, Robinson D, Neufeld T, Altschuler N, Berta A, Hangody L, Veréb Z and Zákány R: Osteogenic differentiation of human bone marrow-derived mesenchymal stem cells is enhanced by an aragonite scaffold. Differentiation. 107:24–34. 2019. View Article : Google Scholar : PubMed/NCBI
24	Motohashi N, Alexander MS, Casar JC and Kunkel LM: Identification of a novel microRNA that regulates the proliferation and differentiation in muscle side population cells. Stem Cells Dev. 21:3031–3043. 2012. View Article : Google Scholar : PubMed/NCBI
25	Luo Y, Zhang Y, Miao G, Zhang Y, Liu Y and Huang Y: Runx1 regulates osteogenic differentiation of BMSCs by inhibiting adipogenesis through Wnt/β-catenin pathway. Arch Oral Biol. 97:176–184. 2019. View Article : Google Scholar : PubMed/NCBI
26	Ji C, Xiaohua L, Li X, Tingting Y, Chaoqun D and Jinyong L: RUNX1 plays an important role in mediating BMP9-Induced osteogenic differentiation of mesenchymal stem cells line C3H10T1/2, murine multi-lineage cells lines C2C12 and MEFs. Int J Mol Sci. 18:13482017. View Article : Google Scholar
27	Saito T, Ohba S, Yano F, Seto I, Yonehara Y, Takato T and Ogasawara T: Runx1 and Runx3 are downstream effectors of nanog in promoting osteogenic differentiation of the mouse mesenchymal cell line C3H10T1/2. Cell Reprogram. 17:227–234. 2015. View Article : Google Scholar : PubMed/NCBI
28	Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, Toyoshima K and Akiyama T: Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level. Genes Cells. 3:395–403. 1998. View Article : Google Scholar : PubMed/NCBI
29	Figeac N and Zammit PS: Coordinated action of Axin1 and Axin2 suppresses β-catenin to regulate muscle stem cell function. Cell Signal. 27:1652–1665. 2015. View Article : Google Scholar : PubMed/NCBI
30	Gwak J, Hwang SG, Park HS, Choi SR, Park SH, Kim H, Ha NC, Bae SJ, Han JK, Kim DE, et al: Small molecule-based disruption of the Axin/β-catenin protein complex regulates mesenchymal stem cell differentiation. Cell Res. 22:237–247. 2012. View Article : Google Scholar : PubMed/NCBI
31	Wu ZQ, Brabletz T, Fearon E, Willis AL, Hu CY, Li XY and Weiss SJ: Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity. Proc Natl Acad Sci USA. 109:11312–11317. 2012. View Article : Google Scholar : PubMed/NCBI
32	Chimge NO, Little GH, Baniwal SK, Adisetiyo H, Xie Y, Zhang T, O'Laughlin A, Liu ZY, Ulrich P, Martin A, et al: RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer. Nat Commun. 7:107512016. View Article : Google Scholar : PubMed/NCBI
33	Wang Y, Wang Y, Zhong T, Guo J, Li L, Zhang H and Wang L: Transcriptional regulation of pig GYS1 gene by glycogen synthase kinase 3β (GSK3β). Mol Cell Biochem. 424:203–208. 2017. View Article : Google Scholar : PubMed/NCBI
34	Chen RJ, Zhang G, Garfield SH, Shi YJ, Chen KG, Robey PG and Leapman RD: Variations in glycogen synthesis in human pluripotent stem cells with altered pluripotent states. PLoS One. 10:e01425542015. View Article : Google Scholar : PubMed/NCBI
35	Contaldo C, Myers TJ, Zucchini C, Manara MC, Chiodoni C, Colombo MP, Nicoletti G, Lollini PL, Li T, Longobardi L, et al: Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells. Growth Factors. 32:41–52. 2014. View Article : Google Scholar : PubMed/NCBI
36	Ardawi MS: The maximal activity of phosphate-dependent glutaminase and glutamine metabolism in the colon and the small intestine of streptozotocin-diabetic rats. Diabetologia. 30:109–114. 1987.PubMed/NCBI
37	Yu Y, Newman H, Shen L, Sharma D, Hu G, Mirando AJ, Zhang H, Knudsen E, Zhang GF, Hilton MJ and Karner CM: Glutamine metabolism regulates proliferation and lineage allocation in skeletal stem cells. Cell Metab. 29:966–978.e4. 2019. View Article : Google Scholar : PubMed/NCBI
38	Matsumoto T, Ii M, Nishimura H, Shoji T, Mifune Y, Kawamoto A, Kuroda R, Fukui T, Kawakami Y, Kuroda T, et al: Lnk-dependent axis of SCF-cKit signal for osteogenesis in bone fracture healing. J Exp Med. 207:2207–2223. 2010. View Article : Google Scholar : PubMed/NCBI
39	Zhang YM, Zhang ZQ, Liu YY, Zhou X, Shi XH, Jiang Q, Fan DL and Cao C: Requirement of Gαi1/3-Gab1 signaling complex for keratinocyte growth factor-induced PI3K-Akt-mTORC1 activation. J Invest Dermatol. 135:181–191. 2015. View Article : Google Scholar : PubMed/NCBI
40	Liu L, Shao L, Li B, Zong C, Li J, Zheng Q, Tong X, Gao C and Wang J: Extracellular signal-regulated kinase1/2 activated by fluid shear stress promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells through novel signaling pathways. Int J Biochem Cell Biol. 43:1591–1601. 2011. View Article : Google Scholar : PubMed/NCBI
41	Liu Q, Lei L, Yu T, Jiang T and Kang Y: Effect of brain-derived neurotrophic factor on the neurogenesis and osteogenesis in bone engineering. Tissue Eng Part A. 24:1283–1292. 2018. View Article : Google Scholar : PubMed/NCBI
42	Hirohiko O, Kaya Y, Hiroyuki M, Jumpei T, Kazuhiko O, Tatsuji H and Akihito Y: Role of protein phosphatase 2A in osteoblast differentiation and function. J Clin Med. 6:232017. View Article : Google Scholar
43	Stechschulte LA, Ge C, Hinds TD, Sanchez ER and Lecka-Czernik B: Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPARγ (peroxisome proliferator-activated receptor γ) and RUNX2 (runt-related transcription factor 2). J Biol Chem. 291:24475–24486. 2016. View Article : Google Scholar : PubMed/NCBI